1. Read, PE, Ash, DV, Thorogood, J, Benson, EA. Short term morbidity and cosmesis following lumpectomy and radical radiotherapy for operable breast cancer. Clin Radiol. 1987;38(4):371-373. doi: 10.1016/s0009-9260(87)80222-2
Google Scholar | Crossref | Medline2. Yarnold, J, Ashton, A, Bliss, J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol. 2005;75(1):9-17. doi: 10.1016/j.radonc.2005.01.005
Google Scholar | Crossref | Medline | ISI3. James, ML, Lehman, M, Hider, PN, Jeffery, M, Hickey, BE, Francis, DP. Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst Rev. 2010(11):CD003860. doi: 10.1002/14651858.CD003860.pub3
Google Scholar | Medline4. Fadavi, P, Nafissi, N, Mahdavi, SR, Jafarnejadi, B, Javadinia, SA. Outcome of hypofractionated breast irradiation and intraoperative electron boost in early breast cancer: a randomized non-inferiority clinical trial. Cancer reports (Hoboken, N.J.). 2021;4(5):e1376. doi:10.1002/cnr2.1376
Google Scholar | Medline5. Smith, BD, Bentzen, SM, Correa, CR, et al. Fractionation for whole breast irradiation: an American society for radiation oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;81(1):59-68. doi.org/10.1016/j.ijrobp.2010.04.042
Google Scholar | Crossref | Medline6. Lee, HH, Chen, CH, Luo, KH, et al. Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or tomotherapy for breast cancer. Sci Rep. 2020;10(1):4342. doi:10.1038/s41598-020-61403-6
Google Scholar | Crossref | Medline7. Ratosa, I, Chirilă, ME, Steinacher, M, et al. Hypofractionated radiation therapy for breast cancer: preferences among radiation oncologists in Europe – results from an international survey. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2021;155:17-26. doi.org/10.1016/j.radonc.2020.10.008
Google Scholar | Crossref | Medline8. Chadha, M, Vongtama, D, Friedmann, P, et al. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer. 2012;12(1):57-62. doi: 10.1016/j.clbc.2011.09.002
Google Scholar | Crossref | Medline9. Fiorentino, A, Mazzola, R, Ricchetti, F, et al. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity. Cancer Radiother. 2015;19(5):289-294. doi: 10.1016/j.canrad.2015.02.013
Google Scholar | Crossref | Medline10. von Elm, E, Altman, DG, Egger, M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577.
Google Scholar | Crossref | Medline | ISI11. Soroosh, D, Javadinia S, A. The COVID-19 outbreak and oncology centers in Iran. Int J Cancer Manag. Online Ahead of Print. 2020;13(6):e103283. doi: 10.5812/ijcm.103283
Google Scholar12. START Trialists’ Group , Bentzen, SM, Agrawal, RK, Aird, EG, et al. The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9(4):331-341. doi: 10.1016/S1470-2045(08)70077-9
Google Scholar | Crossref | Medline13. START Trialists’ Group , Bentzen, SM, Agrawal, RK, Aird, EG, et al. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618):1098-1107. doi: 10.1016/S0140-6736(08)60348-7
Google Scholar | Crossref | Medline14. Owen, JR, Ashton, A, Bliss, JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006;7(6):467-471. doi: 10.1016/S1470-2045(06)70699-4
Google Scholar | Crossref | Medline | ISI15. Whelan, TJ, Pignol, JP, Levine, MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513-520. doi:10.1056/NEJMoa0906260
Google Scholar | Crossref | Medline | ISI16. Van Parijs, H, Miedema, G, Vinh-Hung, V, et al. Short course radiotherapy with simultaneous integrated boost for stage I–II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol. 2012;7(1):80. doi: 10.1186/1748-717X-7-80
Google Scholar | Crossref | Medline17. Lakosi, F, Gulyban, A, Janvary, L, et al. Respiratory motion, anterior heart displacement and heart dosimetry: comparison between prone (Pr) and supine (Su) whole breast irradiation. Pathol Oncol Res. 2015;21(4):1051-1058. doi: 10.1007/s12253-015-9932-9
Google Scholar | Crossref | Medline18. Osa, EO, Dewyngaert, K, Roses, D, et al. Prone breast intensity modulated radiation therapy: 5-year results. Int J Radiat Oncol Biol Phys. 2014;89(4):899-906. doi: 10.1016/j.ijrobp.2014.03.036
Google Scholar | Crossref | Medline19. Formenti, SC, Gidea-Addeo, D, Goldbergn, JD, et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol. 2007;25(16):2236-2242. doi: 10.1200/JCO.2006.09.1041
Google Scholar | Crossref | Medline20. Cante, D, Petrucci, E, Sciacero, P, et al. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer. Med Oncol. 2017;34(9):152. doi: 10.1007/s12032-017-1020-4
Google Scholar | Crossref | Medline21. Kyrgias, G, Zygogianni, A, Theodorou, K, et al. Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer. Am J Clin Oncol. 2015;38(4):358-363. doi: 10.1097/COC.0b013e3182a46740
Google Scholar | Crossref | Medline22. Cante, D, Franco, P, Sciacero, P, et al. Hypofractionation and concomitant boost to deliver adjuvant whole-breast radiation in ductal carcinoma in situ (DCIS): a subgroup analysis of a prospective case series. Medical Oncology. 2014;31(2):838. doi: 10.1007/s12032-014-0838-2
Google Scholar | Crossref | Medline23. Fiorentino, A, Gregucci, F, Mazzola, R, et al. Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities. Radiol Med. 2019;124(4):309-314. doi:10.1007/s11547-018-0976-2
Google Scholar | Crossref | Medline24. Bohlius, J, Reiser, M, Schwarzer, G, Engert, A. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Cochrane Database Syst Rev. 2004;3(3):CD003189. doi: 10.1002/14651858.CD003189.pub3
Google Scholar25. Ippolito, E, Rinaldi, CG, Silipigni, S, et al. Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study. Br J Radiol. 2019;92(1095):20180169. doi: 10.1259/bjr.20180169
Google Scholar | Crossref | Medline26. De Santis, MC, Bonfantini, F, Di Salvo, F, et al. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. The Breast. 2016;29:90-95. doi: 10.1016/j.breast.2016.07.013
Google Scholar | Crossref | Medline27. Kouloulias, V, Zygogianni, A, Kypraiou, E, et al. Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer. World J Clin Cases. 2014;2(11):705-710. doi: 10.12998/wjcc. v2.i11.705
Google Scholar | Crossref | Medline28. Kraus-Tiefenbacher, U, Sfintizky, A, Welzel, G, et al. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiat Oncol. 2012;7(1):217. doi: 10.1186/1748-717X-7-217
Google Scholar | Crossref | Medline29. Freedman, GM, Anderson, PR, Li, J, et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol. 2006;29(1):66-70. doi: 10.1097/01.coc.0000197661.09628.03
Google Scholar | Crossref | Medline